New Delhi [India], April 20 (ANI): Finance Minister Nirmala Sitharaman has approved a total of Rs 4,567.50 crore as advance payment to Serum Institute of India (SII) and Bharat Biotech to ramp up vaccine production against coronavirus, sources told ANI.
New Delhi [India], April 19 (ANI): Congress MP Manickam Tagore on Monday wrote a letter to Prime Minister Narendra Modi seeking adequate supply of vaccines to Tamil Nadu, adding the state has received 7.41 lakh doses of Covishield and 1.75 lakh doses of Covaxin tas against 54 lakh doses of v
New Delhi [India], April 13 (ANI): Union Health Minister Dr Harsh Vardhan on Tuesday accepted that Russia's Sputnik V vaccine against coronavirus has got the emergency use authorisation, making it the third vaccine apart from Covishield and Covaxin to be used in India.
Thiruvananthapuram (Kerala) [India], April 12 (ANI): Kerala Health Minister KK Shailaja on Monday said that so far 50,71,550 doses of COVID-19 vaccines, including 49,19,234 doses of Covishield and 1,52,316 does of Covaxin, have been administered in the state. She also informed that 2,38,7
Mumbai (Maharashtra) [India], April 10 (ANI): The Brihanmumbai Municipal Corporation (BMC) on Saturday said it received 99,000 doses of the Covishield vaccine.
Bhubaneswar (Odisha) [India], April 8 (ANI): Odisha Health Minister, Naba Kisore Das has written to Union Health Minister Dr Harsh Vardhan requesting the supply of at least 10 days stock (or 25 lakh doses) of Covishield vaccine to the state immediately for effective vaccination of the targe
New Delhi (India) [India], April 5 (ANI): Pharmaceutical Company Zydus Cadila on Monday informed that it has sought approval of the Drugs Controller General of India (DGCI) for using its hepatitis drug for the treatment of coronavirus.
New Delhi [India], April 1 (ANI): COVID-19 vaccination will be carried out at both public and private sector Vaccination Centres (CVCs) on all days of April, including gazetted holidays, the central government informed on Thursday.
New Delhi [India], March 27 (ANI): Pune-based Serum Institute of India CEO Adar Poonawalla on Saturday informed that the trials for 'Covovax', a vaccine developed by Novavax, have begun in India, and added that he is hoping the vaccine launch will take place by September this year.